UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis

Leukemia, 2016-01, Vol.30 (1), p.136-143

2016

Volltextzugriff (PDF)

Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event

Leukemia, 2015-05, Vol.29 (5), p.1115-1122

2015

Volltextzugriff (PDF)

Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis

Leukemia, 2016-12, Vol.30 (12), p.2342-2350

2016

Volltextzugriff (PDF)

Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia

Leukemia, 2017-10, Vol.31 (10), p.2271-2273

2017

Volltextzugriff (PDF)

Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phase

Leukemia, 2013-11, Vol.27 (11), p.2254-2256

2013

Volltextzugriff (PDF)

Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis

Haematologica (Roma), 2010-05, Vol.95 (5), p.738-744

2010

Volltextzugriff (PDF)

Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutation

Leukemia, 2012-01, Vol.26 (1), p.162-164

2012

Volltextzugriff (PDF)

Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany

Leukemia, 2009-03, Vol.23 (3), p.602-604

2009

Volltextzugriff (PDF)

BCR-ABL-negative myeloproliferative Neoplasien

Der Onkologe, 2012-12, Vol.18 (12), p.1130-1138

2012

Volltextzugriff (PDF)

Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma

Leukemia, 2007-06, Vol.21 (6), p.1183-1188

2007

Volltextzugriff (PDF)

Erythroferrone (ERFE) and Growth Differentiation Factor 15 (GDF15) Are Overexpressed in Erythroprogenitor Cells of MDS Patients and Associated with Survival

Leukemia research, 2017-04, Vol.55, p.S100-S101

2017

Volltextzugriff (PDF)

Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions

Cytopathology (Oxford), 2008-08, Vol.19 (4), p.205-211

2008

Volltextzugriff (PDF)

The severity of FIP1L1-PDGFRA-positive chronic eosinophilic leukaemia is associated with polymorphic variation at the IL5RA locus

Leukemia, 2007-12, Vol.21 (12), p.2428-2432

2007

Volltextzugriff (PDF)

O-013 Mesenchymal stromal cells support significant engraftment of low-risk myelodysplastic syndromes (MDS) in a murine xenograft model

Leukemia research, 2013-05, Vol.37, p.S14-S14

2013

Volltextzugriff (PDF)

The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis

Annals of hematology, 2014-01, Vol.93 (1), p.81-88

2014

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04c-MDS Mouse models (GEMMS, PDX): OPTIMIZATION OF MDS PATIENT-DERIVED XENOGRAFT (PDX) MODELS BY COMPARISON OF NSG AND NBSGW MICE

Leukemia research, 2023-05, Vol.128, p.107182, Article 107182

2023

Volltextzugriff (PDF)

Iron deficiency anemia and anemia of chronic disorders

Der Internist (Berlin), 2015-09, Vol.56 (9), p.978-988

2015

Volltextzugriff (PDF)

Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: AUGMENTED ACTIVITY OF THE ALVOCIDIB AND 5-AZACYTIDINE COMBINATION IN MYELODYSPLASTIC NEOPLASMS IS ASSOCIATED WITH THE PRESENCE OF ASXL1 MUTATIONS

Leukemia research, 2023-05, Vol.128, p.107238, Article 107238

2023

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche

Leukemia research, 2021-09, Vol.108, p.106680, Article 106680.2

2021

Volltextzugriff (PDF)

O15 - Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: BONE MARROW DERIVED STROMAL CELLS FROM MYELODYSPLASTIC SYNDROMES ARE ALTERED BUT NOT CLONALLY MUTATED IN VIVO

Leukemia research, 2021-09, Vol.108

2021

Volltextzugriff (PDF)

5-AZACYTIDINE IN COMBINATION WITH A NOVEL PAN-LYSYL OXIDASE INHIBITOR SYNERGISTICALLY RESTORES ERYTHROPOIESIS IN MYELODYSPLASTIC MALIGNANCIES

Leukemia research, 2023-05, Vol.128, p.107125, Article 107125

2023

Volltextzugriff (PDF)

Topic: AS08-Treatment/AS08e-New developments - Preclinical studies

Leukemia research, 2021-09, Vol.108, p.106678, Article 106678.2

2021

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(52)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(25)
Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Hematology
(20)
Oncology
(16)
Male
(15)
Middle Aged
(15)
Aged
(13)
Biological And Medical Sciences
(12)
Leukemia
(12)
Medical Sciences
(12)
Adult
(11)
Female
(10)
Hematologic And Hematopoietic Diseases
(10)
Genetic Aspects
(9)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(9)
Patients
(9)
Mutation
(8)
Adolescent
(7)
Diagnosis
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis

Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event

Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis

Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia

Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)

Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phase

Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis

Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutation

Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany

BCR-ABL-negative myeloproliferative Neoplasien

Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma

Erythroferrone (ERFE) and Growth Differentiation Factor 15 (GDF15) Are Overexpressed in Erythroprogenitor Cells of MDS Patients and Associated with Survival

S169: CLINICAL AND MOLECULAR MARKERS FOR PREDICTING RESPONSE TO ROMIPLOSTIM TREATMENT IN LOWER‐RISK MYELODYSPLASTIC SYNDROMES

Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions

The severity of FIP1L1-PDGFRA-positive chronic eosinophilic leukaemia is associated with polymorphic variation at the IL5RA locus

O-013 Mesenchymal stromal cells support significant engraftment of low-risk myelodysplastic syndromes (MDS) in a murine xenograft model

The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis

Randomized comparison of interferon α and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon α and hydroxyurea

Topic: AS04-MDS Biology and Pathogenesis/AS04c-MDS Mouse models (GEMMS, PDX): OPTIMIZATION OF MDS PATIENT-DERIVED XENOGRAFT (PDX) MODELS BY COMPARISON OF NSG AND NBSGW MICE

Iron deficiency anemia and anemia of chronic disorders

Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: AUGMENTED ACTIVITY OF THE ALVOCIDIB AND 5-AZACYTIDINE COMBINATION IN MYELODYSPLASTIC NEOPLASMS IS ASSOCIATED WITH THE PRESENCE OF ASXL1 MUTATIONS

Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche

O15 - Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: BONE MARROW DERIVED STROMAL CELLS FROM MYELODYSPLASTIC SYNDROMES ARE ALTERED BUT NOT CLONALLY MUTATED IN VIVO

5-AZACYTIDINE IN COMBINATION WITH A NOVEL PAN-LYSYL OXIDASE INHIBITOR SYNERGISTICALLY RESTORES ERYTHROPOIESIS IN MYELODYSPLASTIC MALIGNANCIES

Topic: AS08-Treatment/AS08e-New developments - Preclinical studies

Suchergebnisse filtern